Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?
CONCLUSIONS: Patients who used rifabutin had worst immune and virological control. This group had more ART-experienced patients. New and simpler regimens are needed for patients who do not respond to previous antiretroviral therapies.
PMID: 30758392 [PubMed - in process]
Source: Memorias do Instituto Oswaldo Cruz - Category: Infectious Diseases Authors: Schmaltz CAS, Demitto FO, Sant'Anna FM, Rolla VC Tags: Mem Inst Oswaldo Cruz Source Type: research
More News: Brazil Health | Databases & Libraries | Infectious Diseases | Study | Tuberculosis | Virology